The Automated Fluorescent Treponemal Antibody (AFTA) procedure developed by the Space Division of Aerojet General Corporation (El Monte, California) was tested in this laboratory as part of a field evaluation sponsored by the Venereal Disease Research Laboratory of the National Communicable Disease Center, Atlanta, Georgia (Stout, Lewis, Duncan, Hunter, and Lantz, 1968) . The reactivity of the automated procedure was compared with that of the manual Fluorescent Treponemal Antibody-Absorption (FTA-ABS) test on sera from patients in various stages of syphilis, from patients giving biological false positive reactions in the reagin tests for syphilis, and from normal individuals. The reproducibility of the AFTA and FTA-ABS tests was also determined.
The purpose of the study was to answer the following questions:
What is the comparative reactivity of the automated and manual procedures?
How well do the two tests agree on sera from each diagnostic category?
Which test is more 'correct' when judged by diagnostic category?
Is one procedure more subject to technical error than the other?
What is the reproducibility of each test?
Methods and material TEST PROCEDURE The AFTA test employed the SeroMatic System (E comprising an electropneumatically controlled slide processor and a microscope stage attachment. The provisional technique for the AFTA test, published by the Venereal Disease Research Laboratory (1968) , was used. The "ground rules' for this study called for constant monitoring of the slide processor with manual correction as needed.
The technique developed at the Venereal Disease Research Laboratory (1969) Repeat testing was usually accomplished within 1 to 4 days after sera were thawed.
TEST OF STATISTICAL SIGNIFICANCE
The normal approximation to the binomial distribution was employed to test the significance of differences between proportions.
Results

REACTIVITY OF FTA-ABS AND AFTA TESTS ON PRESUMED NONSYPHILITIC INDIVIDUALS
FTA-ABS and AFTA test reactivity in presumed nonsyphilitics (100 BFP and 400 normals) is given in Table I . On 100 BFP sera, the specificity of the two tests as defined in Table I (Table III) ; the difference in sensitivity is statistically significant at the 1 per cent. level. (Figure) yielded a within-run variation of 3 plus in one FTA-ABS run and six AFTA runs; a 2 plus variation occurred in two FTA-ABS runs and five AFTA runs; 95 per cent. of all FTA-ABS readings on Serum X were 3 or 4 plus, but only 83 per cent. of all AFTA readings were in this range (Table  VII) .
On Serum Y and Z ( Figure) , the within-run variation of the FTA-ABS test was never as large as 2 plus. Serum Y in the AFTA test varied by 4 plus in one run, by 3 plus in one run, and by 2 plus in three runs. Serum Z in the AFTA test showed a 2 plus variation in two runs. On Serum Y (Table VII) 
